For practical purposes, the 12th St Gallen International Expert Consensus on breast cancer [17] recently set up histopathological surrogate parameters based on immunohistochemical analysis of hormone receptor status, Her2-neu amplification and proliferation index according to Ki67 labeling. This evidence concerns the gene NR4A1 and breast carcinoma.